about
Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides.Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.Targeting cytotoxic T lymphocytes for cancer immunotherapy.Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens.CD8+ T-cell specificity is compromised at a defined MHCI/CD8 affinity threshold.Adoptive immunotherapy of disseminated leukemia with TCR-transduced, CD8+ T cells expressing a known endogenous TCR.Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease.
P2860
Q35160569-5153B94C-F9AC-4827-A211-27DD418C1D7BQ35583352-E36E6EAB-A840-4C70-BD36-0A427F23BAC9Q35842135-068446F3-771D-4BFA-842E-4D703291CC0EQ36317151-D84EFBD6-28B5-4366-AD1C-BB44CAFE918CQ37560213-11CEA9AA-E26E-4C6F-9232-E21A6DE5417BQ42176846-5BD19E0E-1289-404F-8CC7-934539CBB439Q43078165-B5860140-F9AC-4DB4-9FD0-380E2760E8C9
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Prospects for immunotherapy of malignant disease.
@ast
Prospects for immunotherapy of malignant disease.
@en
type
label
Prospects for immunotherapy of malignant disease.
@ast
Prospects for immunotherapy of malignant disease.
@en
prefLabel
Prospects for immunotherapy of malignant disease.
@ast
Prospects for immunotherapy of malignant disease.
@en
P2093
P2860
P1476
Prospects for immunotherapy of malignant disease.
@en
P2093
E C Morris
G M Bendle
H J Stauss
P2860
P356
10.1046/J.1365-2249.2003.02055.X
P577
2003-01-01T00:00:00Z